Revolutionizing Ophthalmic Diagnostics.
Precise, AI-powered screening seamlessly recreating professional clinics in a portable standalone device.
The Global Burden.
Over 285 Million people suffer from visual impairments globally. 21 Million suffer due to diabetes, many of which are preventable by early screening.
In India, the ₹10,000 Crore ophthalmology market is severely underserved, leaving rural areas most vulnerable to preventable vision loss.
Meet CHAKSHU.
A smart, standalone eye diagnostic ecosystem combining hardware & AI.
Chakshu(S)
A comprehensive screening device recreating the optometrist's office. Features controlled environmental conditions and novel highly sensitive subjective testing capabilities.
Chakshu(O)
A miniaturized high-resolution camera incorporated for retinal scanning, with integrated electronics feeding directly into auto-diagnostics.
Early Detection. Powered by Insight.
-
AI-Driven Diagnostics
Cloud-based analytics provide real-time diagnostic precision usually confined to expensive clinical infrastructure.
-
Comprehensive Condition Coverage
Detects Diabetic Retinopathy, Glaucoma, Age-Related Macular Degeneration, Retinitis Pigmentosa, and Alzheimer's Disease precursors.
-
Accessible Ecosystem
Securely uploaded cloud data allows specialists to conduct remote consultations globally.
Scalable Impact.
Designed for deployment across governmental frameworks and hospital pipelines.
Government Screening
Empowering Health departments to drive large-scale eye condition screening in rural sectors, panchayats, and academic campuses.
Portable Hospital Infrastructure
Providing affordable, deployable retinal imaging devices for ophthalmology clinics, cutting costs and speeding up diagnostics.
Driven by Expertise.
Dr. Dinesh Verma
CEO & Founder • MBBS, MD AIIMS
Prof. Vinayak Naik
CTO & Co-Founder • PhD Ohio State, Faculty BITS Goa
Dr. Ranadhir Mukhopadhyay
Director • Ex Deputy Director NIO
Tanay Naik Govekar
Optical Physicist • BSc. Phy
Rudra Krishna
XR & Web Engineer • BSc. CS
Advance with Visionostics.
Contact our team to discuss large-scale deployment, institutional partnerships, or investment inquiries.